 |
 |

Topical Oxytetracycline-Polymyxin—Further ObservationsUse of Powder Without Allergic Eczematous Reactions
SHERWOOD W. BAREFOOT, M.D.
Arch Dermatol. 1962;86(2):236.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
In 1959, I reported on the use of oxytetracycline hydrochloride (Terramycin)-polymyxin B sulfate powder* in 5,691 patients without significant allergic reactions.1 Since that report, I have had the opportunity to use this preparation on more than 5,500 additional patients with dermatological problems similar to those in the previous report.
Summary
Together with 5,691 cases in a previous report, the present series of 5,500 cases brings to over 11,000 the total number of patients treated by me with a powder containing 3.31% oxytetracycline hydrochloride and 0.144% polymyxin B sulfate in U.S.P. lactose. In not a single case has there been observed a definite instance of eczematous dermatitis from the topical use of oxytetracycline hydrochloride or of polymyxin B sulfate.
Conclusion
With the powder preparation studied, allergic eczematous dermatitis from the topical use of oxytetracycline hydrochloride or polymyxin B sulfate would seem to be virtually nonexistent.
Sherwood W. Barefoot, M.D., 1030
. . . [Full Text PDF of this Article]
Author Affiliations
GREENSBORO, N.C.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|